Krebs Biochemicals & Industries (BOM:524518) PB Ratio: (As of Aug. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524518 Krebs Biochemicals & Industries Ltd BOM:524518
40 GF Score
Price ₹57.25
GF Value ₹37.88
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Krebs Biochemicals & Industries PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-10), Krebs Biochemicals & Industries's share price is ₹57.25. Krebs Biochemicals & Industries's Book Value per Share for the quarter that ended in Mar. 2026 was ₹-75.49. Hence, Krebs Biochemicals & Industries's PB Ratio of today is .

The historical rank and industry rank for Krebs Biochemicals & Industries's PB Ratio or its related term are showing as below:

During the past 13 years, Krebs Biochemicals & Industries's highest PB Ratio was 103.27. The lowest was 21.67. And the median was 27.03.

BOM:524518's PB Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.96
* Ranked among companies with meaningful PB Ratio only.

During the past 3 years, the average Book Value Per Share Growth Rate was -17.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -27.10% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Krebs Biochemicals & Industries was -16.90% per year. The lowest was -64.70% per year. And the median was -37.90% per year.

Back to Basics: PB Ratio


Krebs Biochemicals & Industries  (BOM:524518) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Krebs Biochemicals & Industries PB Ratio Related Terms


Krebs Biochemicals & Industries PB Ratio Historical Data

* Premium members only.

The historical data trend for Krebs Biochemicals & Industries's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krebs Biochemicals & Industries PB Ratio Chart

Krebs Biochemicals & Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Krebs Biochemicals & Industries Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:524518 vs ZTS: PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Krebs Biochemicals & Industries's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krebs Biochemicals & Industries PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krebs Biochemicals & Industries's PB Ratio distribution charts can be found below:

* The bar in red indicates where Krebs Biochemicals & Industries's PB Ratio falls into.


BOM:524518
40GF Score
Krebs Biochemicals & Industries Ltd BOM:524518
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krebs Biochemicals & Industries PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Krebs Biochemicals & Industries's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=57.25/-75.486
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Is Krebs Biochemicals & Industries (BOM:524518) Overvalued in 2026?

Based on GuruFocus' analysis, Krebs Biochemicals & Industries stock appears to be overvalued. The current stock price of ₹57.25 is trading 51.1% above its estimated GF Value™ of ₹37.88. GuruFocus considers Krebs Biochemicals & Industries to be Significantly Overvalued.

Key valuation signals for BOM:524518:

  • PB Ratio:
  • GF Value™: ₹37.88 vs. price of ₹57.25 (51.1% above fair value)
  • GF Score™: 40/100 with 4 warning signs

No single metric tells the full story. See the BOM:524518 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krebs Biochemicals & Industries Business Description

Other Exchanges KREBSBIO:India
Address Kothapalli Village, Kasimkota Mandal, Anakapalli, Vishakapatnam, AP, IND, 531 031
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.
40GF Score

Get the complete analysis for BOM:524518

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹57.25
Price
₹37.88
GF Value